![]() Testosterone replacement therapy (TRT) does not increase cardiovascular disease (CVD) risk, according to a new study to be presented at the American Heart Association meeting in Chicago. Researchers led by Jeffrey Anderson, MD, of the Intermountain Medical Center Heart Institute in Utah observed 5,695 men between the ages of 53 to 71 who were being treated for having low levels of testosterone. They found that men who were receiving testosterone supplementation to reach normal levels of testosterone actually had reduced overall rates of major CVD events at 1 to 3 years after initial levels were measured. The lower rate of CVD risk included a reduction in adjusted death risk and heart attack incidence. “Testosterone therapy has become very popular in the U.S. in recent years,” Dr. Anderson said. “With this study, we are getting closer to defining the true associations between testosterone treatment and CVD risks or benefits.” Currently more than a million patients receive testosterone therapy, with men over the age of 40 making up 70% of the prescriptions. Previous studies have shown that low testosterone pose an increase CVD risk, but the risk in supplementation has not been thoroughly examined.
1 Comment
Kunal Biswas
16/9/2023 17:29:55
Thank you for providing such an informative and well-structured blog post. The information you shared was well-documented, and I appreciated the additional resources and references you included for further reading. To learn more, <a href="https://grovexboost.com/#aff=biswas7398" target="_blank">click here</a>.
Reply
Leave a Reply. |
Σχετικά
Με το ιστολόγιο αυτό επιχειρείται η κατά το δυνατόν άμεση ενημέρωση σε θέματα που αφορούν ουρολογικές εξελίξεις και δίνεται η δυνατότητα σχολιασμού των αναρτήσεων. Κατηγορίες
All
|
Ιατρείο Λαγκαδά: Δ. Μήλιου 24 (έναντι 1ου δημοτικού), Λαγκαδάς
Τ: 2394 020 780, Κ: 693 63 23 794 |